Saturday, February 20, 2021 7:01:25 AM
On Theralase's website there is a drug pipeline graphic (https://theralase.com/anti-cancer-therapy/pipeline/) displaying the following information (which I've failed to grab and post here in a nice way). It really is quite amazing and promising, what they've got going on:
Discovery / Preclinical / Phase I / Phase II / Phase III
TLD-1433 (INTRAVESICAL PHOTODYNAMIC THERAPY PLATFORM TECHNOLOGY) - NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Pivotal Phase II Clinical Study
RUTHERRIN ® (ENHANCED RADIATION THERAPY PLATFORM TECHNOLOGY OR TECHNOLOGY FOR INNOVATION IN RADIATION ONCOLOGY) – GLIOBLASTOMA MULTIFORME (GBM)
Late Preclinical Stage
RUTHERRIN ® (ENHANCED RADIATION THERAPY PLATFORM TECHNOLOGY OR TECHNOLOGY FOR INNOVATION IN RADIATION ONCOLOGY) – NON-SMALL CELLS LUNG CANCER (NSCLC)
Late Preclinical Stage
RUVACARE(V)® (ANTI-PATHOGEN PLATFORM TECHNOLOGY)- SARS - COV-2 - COVID-19
Preclinical Stage
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM